Decibel Therapeutics Inc (DBTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Laurence E. Reid
Employees:
60
1325 BOYLSTON STREET, SUITE 500, BOSTON, MA 02215
617-370-8701

Decibel Therapeutics, Inc. engages in discovering and developing transformative treatments for hearing and balance disorders. The company's lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. It is also developing DB-ATO and AAV.201 to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the vestibule.

Data derived from most recent annual or quarterly report
Market Cap 101.855 Million Shares Outstanding24.965 Million Avg 30-day Volume 73.243 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.47
Price to Revenue0.0 Debt to Equity0.0 EBITDA-50.798 Million
Price to Book Value0.5924 Operating Margin0.0 Enterprise Value-63.549 Million
Current Ratio8.352 EPS Growth-1.177 Quick Ratio7.976
1 Yr BETA 1.0076 52-week High/Low 8.86 / 1.83 Profit Margin0.0
Operating Cash Flow Growth-31.8124 Altman Z-Score-0.9376 Free Cash Flow to Firm -32.095 Million
Earnings Report2022-08-10
View SEC Filings from DBTX instead.

View recent insider trading info

Funds Holding DBTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DBTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

THOMPSON PETER A.

  • Director
  • 10% Owner
10,000 2022-06-17 1

EXTER NEIL

  • Director
  • 10% Owner
10,000 2022-06-17 1

FINGER ALISON CECILY

  • Director
10,000 2022-06-17 3

CARSON WILLIAM H.

  • Director
10,000 2022-06-17 1

NOCHUR SARA

  • Director
10,000 2022-06-17 3

REID LAURENCE SEE REMARKS

  • Officer
  • Director
187,500 2022-02-25 2

TRASK ANNA SEE REMARKS

  • Officer
52,500 2022-02-25 5

LEIDERMAN ELISABETH CHIEF FINANCIAL OFFICER

  • Officer
52,500 2022-02-25 1

LEE JOHN JUI-JEN CHIEF DEVELOPMENT OFFICER

  • Officer
52,500 2022-02-25 1

HU CYNTHIA W. GENERAL COUNSEL

  • Officer
0 2021-08-16 2

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VIII LLC

ORBIMED GENESIS GP LLC

ORBIMED CAPITAL LLC

  • Director
  • 10% Owner
4,945,192 2021-02-17 0

GLAXOSMITHKLINE PLC

  • Director
1,183,663 2021-02-17 0

CASDIN PARTNERS MASTER FUND, L.P.

  • 10% Owner
1,121,421 2021-02-17 0

FOY MATTHEW

  • Director
  • 10% Owner
1,183,663 2021-02-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

EXTER NEIL - Director - > 10% Owner

2022-06-21 18:45:25 -0400 2022-06-17 A 10,000 a 10,000 direct

NOCHUR SARA - Director

2022-06-21 18:50:46 -0400 2022-06-17 A 10,000 a 10,000 direct

FINGER ALISON CECILY - Director

2022-06-21 18:55:19 -0400 2022-06-17 A 10,000 a 10,000 direct

CARSON WILLIAM H. - Director

2022-06-21 18:54:29 -0400 2022-06-17 A 10,000 a 10,000 direct

THOMPSON PETER A. - Director - > 10% Owner

2022-06-21 18:54:18 -0400 2022-06-17 A 10,000 a 10,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 21:15:05 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 20:45:04 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 20:15:06 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 19:45:04 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 19:15:05 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 18:45:04 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 18:15:04 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 17:45:04 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 17:15:04 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 16:45:04 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 16:15:03 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 15:45:05 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 15:15:05 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 14:45:04 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 14:15:03 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 13:45:03 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 13:15:04 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-10 12:45:05 UTC 0.7932 1.5268 350000
DECIBEL THERAPEUTICS INC DBTX 2022-08-09 22:15:07 UTC 0.7932 1.5268 300000
DECIBEL THERAPEUTICS INC DBTX 2022-08-09 21:45:04 UTC 0.7932 1.5268 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments